Innovative Psychiatry
Young people suffering from treatment-resistant depression (TRD) showed a significant reduction of their symptoms after being administered ketamine injections, according to a study published in the Journal of Child and Adolescent Psychopharmacology. Researchers from the University of Minnesota (UM) and the nonprofit Mayo Clinic found that ketamine caused an average decrease of 42 percent on the Children’s […]
Johnson & Johnson and Allergan are now testing new drugs for depression that are based on ketamine. There are still safety concerns. Ketamine, a powerful anesthetic drug, is inspiring scientists and doctors to rethink how we treat depression.Now, two major pharmaceutical companies, Johnson & Johnson and Allergan, are making strides in developing drugs based on […]
After 35 years of mediocre depression drugs, pharmaceutical companies are jazzed about several new drugs inspired by the club drug ketamine. Allergan, the multinational pharmaceutical giant known for Botox and birth control, recently dove into research on an injectable depression drug called Rapastinel. Most recently, the company announced it was working on oral pill version […]
More research backs the club drug ketamine, or “Special K,” for treating severe depression in therapeutic settings. British researchers tested the drug on patients in the U.K. to see if ketamine, which has shown promise in previous trials for treating serious and suicidal depression, might be beneficial in an NHS hospital setting. The NHS is […]
Depression researchers at Black Dog Institute and University of NSW had to abort a “promising” pilot trial into the efficacy of ketamine nasal sprays after patients experienced psychotic-like effects and temporary loss of fine motor skills. The researchers were hopeful the trial would work as an earlier study in the US had shown ketamine – […]
The notorious party drug may act as an antidepressant by blocking neural bursts in a little-understood brain region that may drive depression. By Simon Makin on March 2, 2018 Ketamine has been called the biggest thing to happen to psychiatry in 50 years, due to its uniquely rapid and sustained antidepressant effects. It improves symptoms in as little as 30 […]
Identifying way in which ketamine rapidly alleviates severe depression could pave way for new generation of treatments. Ketamine, most commonly known for its use as a recreational drug, has in recent years come to be thought of as the biggest breakthrough psychiatric treatment for severe depression in half a century. In as little as half an hour it has been shown to banish severe and […]
Anne Stallings says she has been battling severe depression for most of her life. She tried anti-depressants and even electroconvulsive therapy, but nothing worked until she went to a Potomac, Maryland, clinic and tried ketamine, reports CBS News correspondent Paula Reid. “It was like the fifth treatment in and I had come home from the […]
By ERIC W. DOLAN January 24, 2018 The first placebo-controlled study of ketamine’s effect on social anxiety disorder has provides more evidence that the anesthetic could be helpful in severe cases. “Many patients with anxiety continue to have impairing symptoms despite the first-line talk therapy (cognitive behavioral therapy) and first-line medications (selective serotonin reuptake inhibitors),” […]
Ketamine, known mostly as a party drug, has assumed a new identity in recent years—as a promising antidepressant. And, though research is still under way, it seems to reduce symptoms of depression very quickly, and in people who haven’t been helped by traditional antidepressants. Now, a study published in the American Journal of Psychiatry finds that for depressed people […]